Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

DRUG MARKETING

Pharmaceutical companies are bombarding the airwaves with TV ads, showering doctors with gifts to get them to prescribe more of their drugs, and practicing other marketing tactics that can get them into hot water. The topic of drug marketing will examine the myriad ways the industry pushes its products -- and the inevitable controversies that result.

Drug Marketing is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 510 news and 1,068 blog items. Read updated news, blogs, and resources about Drug Marketing. Find user-submitted articles and reactions on Drug Marketing from like-minded professionals.

Most Active

The most active stories in this topic based on user activity.

PhRMA Proposes FDA-Approved Logo for Social-Media Marketing - Advertis...more

NEW YORK (AdAge.com) -- PhRMA is advocating for a universal safety symbol -- either the FDA logo itself or an...

Obama Wants to Avoid Health-Care-Reform Ad War - Advertising Agemore

NEW YORK (AdAge.com) -- If supporters of health-care legislation seem like they're in a hurry to get a bill passed, it...

With Resveratrol, Buyer Bewaremore

Dietary supplement sellers are trying to cash in on the frenzy over red wine.

Are TV ads causing cancer patients to distrust their providers?more

Industry Funded Medical Writers Vs. Health Care Reformmore

A medical writing company uses questionable marketing practices.

Elsevier: 'Fake Journals Were Unacceptable'more

The look-alike journals were funded by pharmaceutical clients including Merck, which is under investigation in the...

Resveratrol: The Hard Sell on Anti-Agingmore

An informative article by Arlene Weintraub of BusinessWeek. Although many stories about resveratrol have been featured...

Medtronic consultant didn't disclose company tiesmore

Dr. David Polly of the University of Minnesota is the second paid consultant to be snared by Sen. Charles Grassley's...

Pot-Friendly California: Amsterdam In America?more

More than a dozen years ago, California became the first state to legalize medical marijuana for people with serious...

Are generic drugs really equivalent to brand name drugs?more

Generic-drug maker Teva steals market share from Big Pharmamore

The Israeli generic-drug maker has an ambitious growth strategy.

Democrats Go to Bat for Big Pharma more

Should a branded biotech get 5 years or 12 years of protection from generic competition?

Drugmakers May Fund Ad Campaign on Health Overhaulmore

Drugmakers may push for an overhaul of the U.S. health care system by spending $100 million on ads starting as early as...

Senator Moves to Stop Scientific Ghostwritingmore

Senator Charles E. Grassley, an Iowa Republican who has led a long-running investigation of conflicts of interest in...

Merck, Schering-Plough Resolve Vytorin Suitmore

The soon-to-merge drug giants have agreed to resolve a pending class action suit over their cholesterol drugs Vytorin...

What Ills Can the Pfizer-Wyeth Merger Cure?more

Wharton professors weigh in on the pros and cons of the deal.

The Neurontin Legacymore

A recent New England Journal article examines the impact of a major legal case on drug marketing.

Arthritis drugs raise cancer risk in kidsmore

J&J and Amgen are among the companies that will have to revise product labels to reflect the risk.

Vermont Lawmakers Sanction Marketing Restrictionsmore

A new bill would add further transparency to financial deals between pharmaceutical companies and doctors.

Drug Firms' Spending on Consumer Ads Dropmore

Big Pharma spent 8% less in '08 on drug advertising than it did the prior year--a rare pullback.

Merck Won’t Face Punitive Damages in Fosamax Trial more

Merck & Co., facing more than 850 lawsuits over claims that its osteoporosis drug Fosamax may cause irreversible...

Pfizer Suit on Neurontin Is Dropped more

A family dropped its lawsuit after an anonymous donor paid them.

New Rules on Doctors and Medical Firms Amid Ethics Concernsmore

In F.D.A. Files, Claims of Rush to Approve Devices (January 13, 2009) F.D.A. Is Lax on Oversight During Trials, Inquiry...

U.S. advisers call for ban of some pain drugs more

Advisors to the FDA recommended banning Vicodin and Percocet.

Targeting Angiogenesis in Cancermore

Topic Feed: Most active content in Drug Marketing

Top Sources: Drug Marketing

  • adage.com
  • New York Times
  • Reuters
  • money.cnn.com
  • online.wsj.com
  • Chicago Tribune
  • knowledge.wharton.upenn.edu
  • medicinesocialjustice.blogspot.com
  • blogs.nature.com
  • carlatpsychiatry.blogspot.com

Most Active Users in this Topic

see all contributors...

Featured White Papers

Post a Job

Jobs in this Topic

Neighborhood Marketing Sales Representative TruGreen | Melbourne, FL
Posted: Nov 20
Scientist, Pharmacokinetics and Drug Metabolism Allergan | Irvine, CA
Posted: Nov 11
Retail Marketing Director INVISTA | Kennesaw, GA
Posted: Nov 23
Dir, Marketing - RCN Metro RCN | Westborough, MA
Posted: Sep 28
Drug Safety Surveillance Associate Sunrise Systems | Bridgewater, NJ
Posted: Oct 21

Report comment contains invalid characters. ()
cancel
Search Cancel